Vascular Diseases and Metabolic DisordersView this Special Issue
Research Article | Open Access
Chuanhai Zhang, Yibing Weng, Fangxiong Shi, Wanzhu Jin, "The Engrailed-1 Gene Stimulates Brown Adipogenesis", Stem Cells International, vol. 2016, Article ID 7369491, 9 pages, 2016. https://doi.org/10.1155/2016/7369491
The Engrailed-1 Gene Stimulates Brown Adipogenesis
As a thermogenic organ, brown adipose tissue (BAT) has received a great attention in treating obesity and related diseases. It has been reported that brown adipocyte was derived from engrailed-1 (EN1) positive central dermomyotome. However, functions of EN1 in brown adipogenesis are largely unknown. Here we demonstrated that EN1 overexpression increased while EN1 knockdown decreased lipid accumulation and the expressions of key adipogenic genes including PPARγ2 and C/EBPα and mitochondrial OXPHOS as well as BAT specific marker UCP1. Taken together, our findings clearly indicate that EN1 is a positive regulator of brown adipogenesis.
In small mammals, brown adipose tissue (BAT) is a major tissue responsible for nonshivering thermogenesis . The mitochondria of BAT uncouple large amounts of fuel oxidation from ATP for generation of heat . Recently, we demonstrated that transplantation of BAT could prevent obesity development and reverses preexisting obesity [3, 4]. It has been shown that increasing BAT activity by cold exposure could reduce fat mass in human adults [5–7]. These results highlight that increased amount and activity of BAT are a promising avenue to combat obesity and its related diseases such as diabetes.
Brown adipogenesis is regulated by several transcription factors such as peroxisome proliferator-activated receptor γ 2 (PPARγ2), PR domain containing 16 (PRDM16), and CCAAT/enhancer-binding proteins (C/EBPs) [8–11]. The nuclear receptor corepressor RIP140, a ligand-dependent transcriptional repressor, also plays a crucial role in regulating the balance between energy storage and energy expenditure by repressing brown adipocyte differentiation [12–14]. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) and cell death activator A (CIDEA) are highly expressed in BAT which were known to regulate BAT differentiation [15, 16].
It has been demonstrated that myf5 positive progenitor cells are the origin of both brown adipocyte and myoblast . In addition, engrailed-1 (EN1) positive central dermomyotome is also another source of brown adipocyte . The EN1, a murine homologue of the Drosophila homeobox gene engrailed (En), is required for midbrain and cerebellum development and dorsal/ventral patterning of the limbs . The mouse study also demonstrated that the expression of EN1 is critical in the correct development of the brain, limbs, and sternum . However, the physiological function of EN1 during brown adipocytes differentiation has not been well studied.
To investigate the functional roles of EN1 in brown adipocyte, we take advantages of lentiviral mediated EN1 overexpression and/or knockdown technique to demonstrate here that EN1, indeed, promotes brown adipocyte differentiation by stimulating key adipogenic transcription factor, PPARγ2 expression.
2. Materials and Methods
Eight-week-old male C57BL/6J donor mice were purchased from Vital River Laboratory Animal Technology Co. Ltd. Ob/Ob mice were from Nanjing Biomedical Research Institute of Nanjing University. For cold stimulation, C57BL/6J mice were placed in a cold chamber (4°C) or room temperature (RT) for up to 8 hrs with free access to food or water. For diet induced obesity (DIO) studies, 3-week-old male C57BL/6J mice from Vital River Laboratory Animal Technology were fed with either low-fat diet (LFD) or high-fat diet (HFD) for additional 8 weeks. The LFD (12450Bi) and HFD (D12492i) contain 10 kcal% fat and 60 kcal% fat, respectively (Research Diets). Mice were housed in the Office of Laboratory Animal Welfare certified animal facility with a 12-hour light/12-hour dark cycle. All animal studies were conducted with the approval of the Institutional Animal Care and Use Committee of Institute of Zoology, Chinese Academy of Sciences.
2.2. Lentivirus Package and Transfection
HEK293FT cells (Sci-Tech, Shanghai, China) were used in lentivirus package. The cells were maintained in Dulbecco’s Modified Eagle Media (DMEM), supplemented with 10% FBS, 1x antibiotic-antimycotic solution, and 10 μM nonessential amino acid. The coding region of EN1 gene was amplified from a BAT cDNA sample and cloned into pCDH-CMV-MCS-EF1-copGFP Lentivector (System Biosciences, San Francisco, CA, USA). The shEN1 sequences were as follows: F: CCGGGTTCCAGGCAAACCGCTATATCTCGAGATATAGCGGTTTGCCTGGAACTTTTTG, R: AATTCAAAAAGTTCCAGGCAAACCGCTATATCTCGAGATATAGCGGTTTGCCTGGAAC and generate the sequence-verified shRNAs in pLKO.1 (Addgene plasmid # 10878). The shuttle plasmid pCDH-CMV-MCS-EF1-copGFP or pLKO.1 or shEN1-pLKO.1 and lentivirus helper plasmid were cotransfected into HEK293FT cells to produce virus. Forty-eight hours after transient transfection, the fresh lentivirus containing supernatant was harvested for future use.
2.3. Flow Cytometry and Cell Sorting
The primary brown adipocytes were prepared in accordance methods with the previous publication . Floating adipocytes were separated from the SVF (Stromal Vascular Fraction) by centrifugation at 300 ×g for 3 min. SVF was sequentially filtered through 70 μm filters before staining with the following antibodies for 10 min on ice: Sca-1-APC (Miltenyi Biotec, 130-093-223), CD11b-FITC (Miltenyi Biotec, 130-081-201), and CD45-PE (Miltenyi Biotec, 130-091-610). Following antibody incubation, cells were washed, centrifuged at 300 ×g for 10 min, and sorted with a BD FACS Aria (BD Biosciences, CA, USA). Data analysis was performed using BD FACS Diva software.
2.4. Cell Culture
Cell culture related products and most other biochemical reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise specified. After being infected with lentivirus for 6–12 hours, the sorted primary brown fat preadipocytes were grown until 100% in 6-well plates and then treated with brown adipogenic induction cocktails (DMEM containing 10% FBS, 1 μg/mL insulin, 1 μM dexamethasone, 0.5 mM isobutylmethylxanthine, 0.12 mM indomethacin, and 1 nM 3,3′,5-triiodo-L-thyronine (T3)) for the first two days and the medium was replaced with differentiation medium supplemented with only insulin and T3 for additional 6 days for differentiation.
Total RNA was isolated using the RNeasy Mini Kit. cDNA was synthesized using random hexamers (Invitrogen, Carlsbad, CA, USA) for subsequent real-time quantitative PCR analysis (ABI Prism VIIA7; Applied Biosystems Inc., Foster City, CA, USA). PCR products were detected using SYBR Green and normalized by cyclophilin expression. Primers were designed using Primer Quest (Integrated DNA Technologies, Inc., Coralville, IA, USA). Primer sequences were available upon request.
2.6. Western Blotting
Cell and tissue lysates were prepared using RIPA buffer (150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, and protease) and phosphatase inhibitor cocktail (Roche Diagnostics Co., CA, USA). Protein concentrations were measured with a BCA assay kit (Pierce Diagnostics Co., CA, USA). Protein was separated by 10% SDS-PAGE and transferred to PVDF membrane (Millipore, MA, USA). Membranes were blocked in 5% skim milk in TBST (0.02 M Tris base, 0.14 M NaCl, and 0.1% Tween 20, pH 7.4) followed by incubation with primary antibodies overnight at 4°C and then incubation with secondary antibodies conjugated with HRP. Primary antibodies used in the current study are EN1 (ab108598, R&D Systems, MN, USA), PPARγ2 (#2443, Cell Signaling Technology, MA, USA), AP2 (A0232, ABclonal Biotech Co., MA, USA), UCP1 (ab155117, Abcam Co., MA, USA), PGC1α (ab54481, Abcam Co., MA, USA), OXPHOS (ab110413, Abcam Co., MA, USA), and GAPDH (#2118, Cell Signaling Technology, MA, USA). Signals were detected with Super Signal West Pico Chemiluminescent Substrate (Pierce, IL, USA).
2.7. Oil-Red O Staining
To detect neutral lipid, cells were stained with 0.2% (w/v) Oil-Red O (Sigma-Aldrich, St. Louis, MO, USA) for 10 min at room temperature after fixation with 4% PFA.
2.8. Statistical Analysis
The data are presented as means ± SD. Statistical significance was tested using ANOVA or Student’s -test. Statistical significance was set at < 0.05.
3.1. EN1 Is Highly Expressed in BAT Compared to WAT
To investigate the expression of EN1 in related tissues, we analyzed the EN1 mRNA and protein expression in four different tissues: epididymal white adipose tissue (WAT), brown adipose tissue (BAT), brain tissue (BR), and skeletal muscles (MUS) from C57BL/6J male mice at 8 weeks of age fed with normal chow diet. The result showed that both the EN1 mRNA and protein expression were highly enriched in BAT compared with WAT (Figures 1(a)-1(b)). Surprisingly, the EN1 expression in skeletal muscle is several-hundred-fold higher than WAT.
3.2. Expression of EN1 in BAT at Pathophysiological Conditions
Cold exposure is believed to be a most attractive physiological way to activate BAT [5, 21]. Moreover, previous reports have indicated dysfunction of BAT in obesity mice model [3, 4]. To determine the expression of EN1 at pathophysiological conditions, the BAT tissues were analyzed in mice with different treatment, such as room temperature (RT) versus cold exposure (Cold); low-fat diet (LFD) versus high-fat diet (HFD); wild type (WT) versus Ob/Ob mice. Interestingly, the mRNA and protein expression of EN1 were downregulated upon cold exposure (Figures 2(a)-2(b)). In contrast, they were upregulated in obesity mice compared with control mice (Figures 2(c)–2(f)). These results indicate that EN1 might influence BAT lipid contents.
3.3. EN1 Expression during Brown Adipogenesis
The above results led us to hypothesize that EN1 might be involved in brown adipogenesis. To this end, primary brown adipocytes (SCA1+/CD31−/CD11b−; referred to as classical brown adipose tissue progenitor cells) were isolated from fetal C57BL/6J mouse BAT according to previous publications [22, 23] (Figures 3(a)-3(b)). In order to explore the potential role of EN1, we first investigated the mRNA and protein expression of EN1 during brown adipogenesis. Interestingly, the expression of EN1 was downregulated at day 1 and progressively increased during brown adipogenesis up to day 7 (Figures 3(c)-3(d)). These results highlight that EN1 might be involved in brown adipogenesis.
3.4. Overexpression of EN1 Stimulates Brown Adipogenesis
To investigate the possibility of whether EN1 is involved in brown adipogenesis, a lentivirus EN1 overexpression plasmid or empty vector was transfected into primary brown adipocyte and then underwent brown adipogenesis. EN1 expression was successfully upregulated more than 30-fold at three days after viral transduction (Figures 4(a)-4(b)). Interestingly, the lipid accumulation which was assessed by Oil-Red O staining was significantly increased by EN1 overexpression (Figure 4(c)), suggesting that EN1 stimulates brown adipogenesis. Therefore, we investigated the expression of adipogenic genes (AP2, PPARγ2, and C/EBPs), brown adipocyte specific thermogenic proteins, UCP1 and PGC1α, and mitochondrial oxidative phosphorylation (OXPHOS) protein at the end of the brown adipogenesis. Our results showed that both mRNA and protein expression of AP2 and PPARγ2 were dramatically upregulated after EN1 overexpression (Figures 4(d) and 4(f)). In addition, the mRNA expression of C/EBPα was also significantly increased after EN1 overexpression (Figure 4(d)). Furthermore, EN1 overexpression led to significant induction of thermogenic proteins, such as UCP1 and PGC1α, as well as mitochondrial OXPHOS proteins, including ATP5α, UQCRC2, SDHB, and NDUFB8 (Figures 4(e)-4(f)). These results indicated that EN1 promotes brown adipogenesis by upregulating the key adipogenic gene expression.
3.5. Knockdown of EN1 Suppresses Brown Adipogenesis
In order to further verify our results, knockdown of EN1, the complementary approach to overexpression, was applied to brown adipogenesis. Lentivirus encoding Sh-EN1 plasmid or empty vector was transinfected into primary brown adipocytes and underwent brown adipogenesis. We confirmed that EN1 expression was successfully downregulated about 75% at three days after viral transduction (Figures 5(a)-5(b)). As expected, lipid accumulation was significantly decreased by EN1 knockdown (Figure 5(c)). Consistently, both mRNA and protein expression of AP2 and PPARγ2 were dramatically downregulated after shEN1 plasmid transfection (Figures 5(d) and 5(f)). Furthermore, the mRNA expression of C/EBPα was also significantly decreased by EN1 knockdown (Figure 5(d)). Moreover, EN1 knockdown led to significant reduction of thermogenic proteins, UCP1 and PGC1α, as well as mitochondrial OXPHOS proteins, such as ATP5α, UQCRC2, SDHB, and NDUFB8 (Figures 5(e)-5(f)). Taken together, the results from Figures 4-5 clearly indicated that EN1 promotes brown adipogenesis.
In the current study, we investigated the role of EN1 in brown adipogenesis. We demonstrated that EN1 is a positive regulatory factor for brown adipogenesis. To our knowledge, this is first study showing that role of EN1 in brown adipogenesis.
Transplantation of BAT can effectively improve the whole body energy metabolism and prevent metabolic disorders, such as obesity and insulin resistance [3, 4, 7]. Increased amount and/or activity of BAT are critical approaches to combat obesity and related diseases. Generating large volume of brown adipocytes by manipulating genes including EN1 and chemicals could be one of the best approaches in the future.
EN1 is well known as one of the brown adipocyte lineage-tracing markers , yet little is known about its functions in brown adipogenesis. We found that expression of EN1 was higher in BAT than WAT (Figures 1(a)-1(b)). EN1 is required for midbrain and cerebellum development and patterning of the limbs [18, 19]. Consistently, we also confirmed a high expression of EN1 in the brain and muscle.
To investigate the potential role of EN1 in brown adipogenesis, we first determined the expression of EN1 during brown adipogenesis. Interestingly, expression of EN1 is downregulated at day 1 and progressively increased during brown adipogenesis upon day 7. These results prompt us to hypothesize that EN1 might be involved in brown adipocyte differentiation. Interestingly, we found that overexpression of EN1 accelerated while knockdown of EN1 suppressed the brown adipocyte differentiation (Figures 4-5). These results imply that EN1 positively regulates brown adipogenesis.
The major transcriptional factors such as PPARγ2 and C/EBPα interacted with each other to commit adipocyte differentiation . PPARγ1 and PPARγ2, two isoforms of PPARγ, are essential transcriptional factors for both white and brown adipogenesis [25–28]. However, mutation of PPARγ receptor in mice results in impairments of brown adipocyte thermogenic function and recruitment in BAT . In our hands, overexpression of EN1 upregulates while knockdown of EN1 downregulates the PPARγ2 and C/EBPα expression (Figures 4-5). These results indicate that EN1 is involved in brown adipogenesis via regulating expression of PPARγ2 and C/EBPα. However, the exact underlying molecular regulatory mechanisms are remained to be studied.
PGC1α, a coactivator of PPARγ2, also plays an important role in adaptive thermogenesis in BAT by regulating mitochondrial biogenesis and upregulates the expression of UCP1 [8, 30–33]. Furthermore, PRDM16 and C/EBPβ complex synergistically enhances the activity of PGC1α [11, 32]. Interesting to us, the degree of EN1 expression has significant effect on BAT function as determined by mitochondrial OXPHOS protein expression and BAT specific marker gene expression including UCP1 and PGC1α (Figures 4-5).
In addition, the expression of EN1 is dramatically downregulated upon cold exposure, while it is increased in BAT of obesity mice. Moreover, it was significantly increased in BAT of both the high-fat diet (HFD) and Ob/Ob mice, which showed diminished functions of BAT [34, 35]. It was well known that the brown adipogenesis often associated with BAT function . We therefore emphasize that EN1 might reflect the size of lipid droplets in BAT, since it is well known that HFD cause BAT hyperplasia with enlarged lipid droplet. On the other hand, cold exposure results in smaller lipid droplet size in BAT. In line with this speculation, EN1 also might be regulated by beta 3 adrenergic signaling which is important for cold induced BAT activation. Further studies are needed to clarify these hypotheses.
In conclusion, our current study demonstrated that EN1 positively regulated brown adipogenesis and BAT functions via increasing the expressions of thermogenic proteins as well as mitochondrial OXPHOS proteins.
The authors declare that they have no competing interests.
Chuanhai Zhang and Yibing Weng have contributed equally to this work.
This work was supported by the Strategic Priority Research Program (XDB13030000 to Wanzhu Jin) and the Key Research Program (KJZD-EW-L01-3 to Wanzhu Jin) of the Chinese Academy of Sciences.
- B. Cannon and J. Nedergaard, “Brown adipose tissue: function and physiological significance,” Physiological Reviews, vol. 84, no. 1, pp. 277–359, 2004.
- D. G. Nicholls, V. S. Bernson, and G. M. Heaton, “The identification of the component in the inner membrane of brown adipose tissue mitochondria responsible for regulating energy dissipation,” Experientia Supplementum, vol. 32, pp. 89–93, 1978.
- X. Liu, Z. Zheng, X. Zhu et al., “Brown adipose tissue transplantation improves whole-body energy metabolism,” Cell Research, vol. 23, no. 6, pp. 851–854, 2013.
- X. Liu, S. Wang, Y. You et al., “Brown adipose tissue transplantation reverses obesity in Ob/Ob mice,” Endocrinology, vol. 156, no. 7, pp. 2461–2469, 2015.
- K. A. Virtanen, M. E. Lidell, J. Orava et al., “Functional brown adipose tissue in healthy adults,” The New England Journal of Medicine, vol. 360, no. 15, pp. 1518–1525, 2009.
- W. D. van Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders et al., “Cold-activated brown adipose tissue in healthy men,” New England Journal of Medicine, vol. 360, no. 15, pp. 1500–1508, 2009.
- A. M. Cypess, S. Lehman, G. Williams et al., “Identification and importance of brown adipose tissue in adult humans,” The New England Journal of Medicine, vol. 360, no. 15, pp. 1509–1517, 2009.
- P. Seale, S. Kajimura, W. Yang et al., “Transcriptional control of brown fat determination by PRDM16,” Cell Metabolism, vol. 6, no. 1, pp. 38–54, 2007.
- J. A. Timmons, K. Wennmalm, O. Larsson et al., “Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 11, pp. 4401–4406, 2007.
- P. Seale, B. Bjork, W. Yang et al., “PRDM16 controls a brown fat/skeletal muscle switch,” Nature, vol. 454, no. 7207, pp. 961–967, 2008.
- H. Wang, T. H. Peiris, A. Mowery, J. L. Lay, Y. Gao, and L. E. Greenbaum, “CCAAT/enhancer binding protein-β is a transcriptional regulator of peroxisome-proliferator-activated receptor-γ coactivator-1α in the regenerating liver,” Molecular Endocrinology, vol. 22, no. 7, pp. 1596–1605, 2008.
- M. Rosell, M. C. Jones, and M. G. Parker, “Role of nuclear receptor corepressor RIP140 in metabolic syndrome,” Biochimica et Biophysica Acta, vol. 1812, no. 8, pp. 919–928, 2011.
- M. Christian, E. Kiskinis, D. Debevec, G. Leonardsson, R. White, and M. G. Parker, “RIP140-targeted repression of gene expression in adipocytes,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9383–9391, 2005.
- E. Kiskinis, L. Chatzeli, E. Curry et al., “RIP140 represses the ‘brown-in-white’ adipocyte program including a futile cycle of triacyclglycerol breakdown and synthesis,” Molecular Endocrinology, vol. 28, no. 3, pp. 344–356, 2014.
- Z. Zhou, S. Y. Toh, Z. Chen et al., “Cidea-deficient mice have lean phenotype and are resistant to obesity,” Nature Genetics, vol. 35, no. 1, pp. 49–56, 2003.
- F. Fisher, S. Kleiner, N. Douris et al., “FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis,” Genes and Development, vol. 26, no. 3, pp. 271–281, 2012.
- R. Atit, S. K. Sgaier, O. A. Mohamed et al., “β-catenin activation is necessary and sufficient to specify the dorsal dermal fate in the mouse,” Developmental Biology, vol. 296, no. 1, pp. 164–176, 2006.
- S. E. McGrath, A. Michael, H. Pandha, and R. Morgan, “Engrailed homeobox transcription factors as potential markers and targets in cancer,” FEBS Letters, vol. 587, no. 6, pp. 549–554, 2013.
- W. Wurst, A. B. Auerbach, and A. L. Joyner, “Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum,” Development, vol. 120, no. 7, pp. 2065–2075, 1994.
- M. Fasshauer, J. Klein, K. M. Kriauciunas, K. Ueki, M. Benito, and C. R. Kahn, “Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes,” Molecular and Cellular Biology, vol. 21, no. 1, pp. 319–329, 2001.
- P. Schrauwen, W. D. van Marken Lichtenbelt, and B. M. Spiegelman, “The future of brown adipose tissues in the treatment of type 2 diabetes,” Diabetologia, vol. 58, no. 8, pp. 1704–1707, 2015.
- Y. H. Lee and J. G. Granneman, “Seeking the source of adipocytes in adult white adipose tissues,” Adipocyte, vol. 1, no. 4, pp. 230–236, 2014.
- T. Shan, W. Liu, and S. Kuang, “Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues,” FASEB Journal, vol. 27, no. 1, pp. 277–287, 2013.
- E. D. Rosen, “C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway,” Genes & Development, vol. 16, no. 1, pp. 22–26, 2002.
- Y. Barak, M. C. Nelson, E. S. Ong et al., “PPARγ is required for placental, cardiac, and adipose tissue development,” Molecular Cell, vol. 4, no. 4, pp. 585–595, 1999.
- E. D. Rosen, P. Sarraf, A. E. Troy et al., “PPARγ is required for the differentiation of adipose tissue in vivo and in vitro,” Molecular Cell, vol. 4, no. 4, pp. 611–617, 1999.
- P. Tontonoz, E. Hu, and B. M. Spiegelman, “Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor,” Cell, vol. 79, no. 7, pp. 1147–1156, 1994.
- J. Nedergaard, N. Petrovic, E. M. Lindgren, A. Jacobsson, and B. Cannon, “PPARγ in the control of brown adipocyte differentiation,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1740, no. 2, pp. 293–304, 2005.
- S. L. Gray, E. Dalla Nora, E. C. Backlund et al., “Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARγ) function,” Endocrinology, vol. 147, no. 12, pp. 5708–5714, 2006.
- P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman, “A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis,” Cell, vol. 92, no. 6, pp. 829–839, 1998.
- P. Puigserver and B. M. Spiegelman, “Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator,” Endocrine Reviews, vol. 24, no. 1, pp. 78–90, 2003.
- S. Kajimura, P. Seale, K. Kubota et al., “Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex,” Nature, vol. 460, no. 7259, pp. 1154–1158, 2009.
- Z. Wu, P. Puigserver, U. Andersson et al., “Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1,” Cell, vol. 98, no. 1, pp. 115–124, 1999.
- P. U. Dubuc, N. J. Wilden, and H. J. Carlisle, “Fed and fasting thermoregulation in ob/ob mice,” Annals of Nutrition and Metabolism, vol. 29, no. 6, pp. 358–365, 1985.
- R. A. L. Batt and M. Hambi, “Development of the hypothermia in obese mice (genotype ob/ob),” International Journal of Obesity, vol. 6, no. 4, pp. 391–397, 1982.
- S. Carobbio, B. Rosen, and A. Vidal-Puig, “Adipogenesis: new insights into brown adipose tissue differentiation,” Journal of Molecular Endocrinology, vol. 51, no. 3, pp. T75–T85, 2013.
Copyright © 2016 Chuanhai Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.